Dr. Robert Stoler, M.D.
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- Duke University School of Medicine (1990)
- Years since graduation
- 36
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 523
Licensed in Texas since 1991, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1990Medical school: Duke University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
TX license J0287 (first issued 1991; active) -
Cardiovascular Disease Physician
TX license J0287 (first issued 1991; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baylor University Medical Center Dallas, TX
- Hunt Regional Medical Center Greenville, TX
- Baylor Scott & White the Heart Hospital Plano Plano, TX
- Baylor Scott & White Medical Center- Waxahachie Waxahachie, TX
- Baylor Scott & White Heart & Vascular Hospital - Dallas Dallas, TX
Medical groups
- Healthtexas Provider Network (2,697 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 523
- Services billed
- 1,995
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 295 | 281 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 177 | 174 |
| Established patient office or other outpatient visit, 30-39 minutes | 143 | 142 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 126 | 116 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 112 | 98 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 54 | 54 |
| Heart muscle strain imaging | 43 | 42 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 40 | 40 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 39 | 38 |
| Replacement of aortic valve through the skin and femoral artery | 37 | 37 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Dallas, TX | 254 |
| Carvedilol Other prescribers in Dallas, TX | 166 |
| Rosuvastatin Calcium Other prescribers in Dallas, TX | 153 |
| Atorvastatin Calcium Other prescribers in Dallas, TX | 133 |
| Losartan Potassium Other prescribers in Dallas, TX | 116 |
| Metoprolol Succinate Other prescribers in Dallas, TX | 96 |
| Eliquis (apixaban) Other prescribers in Dallas, TX | 95 |
| Lisinopril Other prescribers in Dallas, TX | 70 |
| Amlodipine Besylate Other prescribers in Dallas, TX | 65 |
| Ezetimibe Other prescribers in Dallas, TX | 54 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 146 payments worth $64,818 in total to this clinician.
| Boston Scientific Corporation | $25,765 |
|---|---|
| Medtronic, Inc. | $14,615 |
| Biotronik Inc. | $12,696 |
| Edwards Lifesciences Corporation | $9,406 |
| Teleflex LLC | $1,024 |
| Shockwave Medical, Inc | $583 |
| Spectrawave, Inc | $332 |
| Novartis Pharmaceuticals Corporation | $129 |
| Consulting Fee | $31,738 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $15,313 |
| Food and Beverage | $7,263 |
| Speaking at a medical education program | $6,680 |
| Travel and Lodging | $3,824 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Medtronic, Inc. Oct 7, 2025 | Consulting Fee SYMPLICITY G3 · Renal Denervation System | $10,450 |
| Edwards Lifesciences Corporation Jun 20, 2025 | Consulting Fee EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · Transcatheter Heart Valves | $6,500 |
| Biotronik Inc. Jul 9, 2025 | Consulting FeeCompany’s description132024 | $5,175 |
| Boston Scientific Corporation Jan 3, 2025 | Compensation for services other than consulting (speaking, faculty) General - Vascular Access · General - Vascular Access_IC | $5,000 |
| Biotronik Inc. May 1, 2025 | Speaking at a medical education programCompany’s description131875 | $4,880 |
| Boston Scientific Corporation Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) General - Vascular Access · General - Vascular Access_IC | $3,750 |
| Boston Scientific Corporation Dec 18, 2025 | Consulting Fee General - CT_IC | $3,750 |
| Boston Scientific Corporation Mar 20, 2025 | Compensation for services other than consulting (speaking, faculty) General - Vascular Access · General - Vascular Access_IC | $3,125 |
| Boston Scientific Corporation Apr 10, 2025 | Compensation for services other than consulting (speaking, faculty) General - Vascular Access · General - Vascular Access_IC | $2,500 |
| Boston Scientific Corporation Dec 11, 2025 | Consulting Fee General - CT_IC | $2,500 |
All 33 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Boston Scientific Corporation Dec 18, 2025 | Consulting Fee General - CT_IC | $3,750 |
| Boston Scientific Corporation Dec 18, 2025 | Consulting Fee General - CT_IC | $625 |
| Boston Scientific Corporation Dec 18, 2025 | Consulting Fee General - CT_IC | $625 |
| Boston Scientific Corporation Dec 11, 2025 | Consulting Fee General - CT_IC | $2,500 |
| Boston Scientific Corporation Dec 4, 2025 | Consulting Fee General - Balloon Catheters · General - Balloon Catheters_ICG | $625 |
| Boston Scientific Corporation Nov 28, 2025 | Consulting Fee General - Balloon Catheters · General - Balloon Catheters_ICG | $313 |
| Boston Scientific Corporation Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) General - Vascular Access · General - Vascular Access_IC | $3,750 |
| Boston Scientific Corporation Nov 7, 2025 | Travel and Lodging General - Therapies · General - Therapies_IC · travel to Minneapolis St. Paul, MN · in-kind | $260 |
| Boston Scientific Corporation Nov 7, 2025 | Travel and Lodging General - Therapies · General - Therapies_IC · travel to Minneapolis St. Paul, MN · in-kind | $212 |
| Medtronic, Inc. Oct 7, 2025 | Consulting Fee SYMPLICITY G3 · Renal Denervation System | $10,450 |
| Medtronic, Inc. Oct 6, 2025 | Consulting Fee | $550 |
| Medtronic, Inc. Sep 19, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $583 |
| Medtronic, Inc. Sep 9, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $349 |
| Medtronic, Inc. Sep 9, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $51.04 |
| Medtronic, Inc. Sep 8, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $349 |
| Medtronic, Inc. Sep 8, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $51.04 |
| Biotronik Inc. Jul 9, 2025 | Consulting FeeCompany’s description132024 | $5,175 |
| Edwards Lifesciences Corporation Jun 20, 2025 | Consulting Fee EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · Transcatheter Heart Valves | $6,500 |
| Biotronik Inc. Jun 20, 2025 | Travel and Lodging travel to New York, NY · in-kind Company’s descriptionACH DEBIT1 | $317 |
| Edwards Lifesciences Corporation Jun 9, 2025 | Travel and Lodging EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · Transcatheter Heart Valves · travel to Tyler, TX · in-kind | $266 |
| Biotronik Inc. Jun 5, 2025 | Speaking at a medical education programCompany’s description131944 | $1,800 |
| Medtronic, Inc. May 14, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $18.71 |
| Medtronic, Inc. May 13, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $296 |
| Medtronic, Inc. May 13, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $35.07 |
| Edwards Lifesciences Corporation May 8, 2025 | Travel and Lodging SAPIEN 3 Ultra RESILIA · Transcatheter Heart Valves · travel to Chicago, IL · in-kind | $393 |
| Edwards Lifesciences Corporation May 8, 2025 | Travel and Lodging SAPIEN 3 Ultra RESILIA · Transcatheter Heart Valves · travel to Chicago, IL · in-kind | $173 |
| Biotronik Inc. May 1, 2025 | Speaking at a medical education programCompany’s description131875 | $4,880 |
| Boston Scientific Corporation Apr 10, 2025 | Compensation for services other than consulting (speaking, faculty) General - Vascular Access · General - Vascular Access_IC | $2,500 |
| Boston Scientific Corporation Apr 10, 2025 | Compensation for services other than consulting (speaking, faculty) General - Vascular Access · General - Vascular Access_IC | $938 |
| Boston Scientific Corporation Apr 10, 2025 | Consulting Fee General - Balloons · General - Balloons_PI | $625 |
| Boston Scientific Corporation Mar 20, 2025 | Compensation for services other than consulting (speaking, faculty) General - Vascular Access · General - Vascular Access_IC | $3,125 |
| Edwards Lifesciences Corporation Mar 13, 2025 | Travel and Lodging EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · Transcatheter Heart Valves · travel to Chicago, IL · in-kind | $471 |
| Boston Scientific Corporation Jan 3, 2025 | Compensation for services other than consulting (speaking, faculty) General - Vascular Access · General - Vascular Access_IC | $5,000 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 16 industry-funded studies in 2025, from 7 companies. The companies reported $1,297,936 in research payments for these studies, mostly to the institutions running them.
- SPYRAL AFFIRM
Medtronic, Inc. - Prevail Global
Medtronic, Inc. - ALLIANCE 2021-05
Edwards Lifesciences Corporation - AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
Boston Scientific Corporation · Recruiting · NCT06959524 - ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement
Boston Scientific Corporation · Active, not recruiting · NCT03735667 - Prospective, Multicenter, Single-Arm, Investigational Device Exemption (IDE) Study of the Shockwave Intravascular Lithotripsy (IVL) System With the Shockwave Javelin Coronary IVL Catheter (FORWARD CAD IDE Study)
Shockwave Medical, Inc - A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)
Boston Scientific Corporation · Active, not recruiting · NCT04647253 - BIOFLOW-VII
Biotronik Inc. - A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels
M.a. Med Alliance S.a. - TAVR Low Risk
Medtronic, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.